Overview of age-variations
Age group comparisons |
PMID |
Age/Age interval, Gender |
Value (unit of measurement) |
Method |
Sample |
15708441 |
Age 26 ± 1, Gender ⚥ |
9.58 (nM) |
H-MRS |
motor cortex |
15708441 |
Age 54 ± 6, Gender ⚥ |
8.34 (nM) |
H-MRS |
motor cortex |
23701591 |
Age [54-57], Gender ⚥ (Taiwanese population) |
4.6 (signal intensity) |
HNMR |
urine |
23701591 |
Age [79-91], Gender ⚥ (Taiwanese population) |
5.21 (signal intensity) |
HNMR |
urine |
27374292 |
Age [25–35] (median=32), Gender ♀ (Japanese) |
0.748115 (average level of metabolite) |
UHPLC-MS/MS Positive mode |
serum |
27374292 |
Age [55–65] (median=60), Gender ♀ (Japanese) |
1.089607 (average level of metabolite) |
UHPLC-MS/MS Positive mode |
serum |
27374292 |
Age [25–35] (median=32), Gender ♂ (Japanese) |
0.949468 (average level of metabolite) |
UHPLC-MS/MS Positive mode |
serum |
27374292 |
Age [55–64] (median=60), Gender ♂ (Japanese) |
1.407679 (average level of metabolite) |
UHPLC-MS/MS Positive mode |
serum |
Linear regression |
PMID |
Age/Age interval, Gender |
Value (unit of measurement) |
Method |
Sample |
23838602 |
Age [17–85], Gender ⚥ |
0.016 (β) |
UHPLC/MS/MS |
serum and plasma |
23838602 |
Age [17–85], Gender ⚥ |
1.6 (β) |
UHPLC/MS/MS |
serum and plasma |
23838602 |
Age [17–85], Gender ⚥ |
1.45 (β) |
UHPLC/MS/MS |
serum and plasma |
23838602 |
Age [17–85], Gender ⚥ |
1.75 (β) |
UHPLC/MS/MS |
serum and plasma |
30659340 |
Age [20-70], Gender ⚥ |
-0.034 (β) |
wbMRSI |
occipital gray matter |
30659340 |
Age [20-70], Gender ⚥ |
-0.27 (β) |
wbMRSI |
parietal white matter |
log2 ratio/log2(FC) |
PMID |
Age/Age interval, Gender |
Value (unit of measurement) |
Method |
Sample |